Clal Insurance Enterprises (CLIS) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
10 Nov, 2026Executive summary
9M 2025 net income was NIS 1,543m vs NIS 1,343m; comprehensive income attributable to shareholders was NIS 1,531m vs NIS 1,342m, or NIS 1,631m excluding the estimated post-tax VAT provision impact.
9M pre-tax core income rose 13% to NIS 1,686m from NIS 1,495m; AUM reached NIS 407bn, up from NIS 373bn at December 31, 2024.
Q3 net income was NIS 592m vs NIS 420m; comprehensive income was NIS 590m vs NIS 417m, up 41% YoY.
Shareholders’ equity reached NIS 10.1bn, up from NIS 8.7bn at year-end 2024 and 38% since December 2023.
Financial highlights
9M insurance-service income was NIS 871m vs NIS 744m; net investment and finance income was NIS 1,433m vs NIS 1,163m.
9M gross premiums, pension/provident contributions and investment-contract proceeds totaled NIS 20.7bn vs NIS 20.2bn; Q3 totaled NIS 7.0bn vs NIS 6.8bn.
9M basic EPS was NIS 19.32 vs NIS 16.93; diluted EPS was NIS 18.60 vs NIS 16.90. Q3 basic EPS was NIS 7.41 vs NIS 5.28.
Assets were NIS 183.7bn and shareholder equity NIS 10.1bn at September 30, 2025, vs NIS 173.0bn and NIS 8.7bn at year-end 2024.
Outlook and guidance
Bank of Israel forecasts GDP growth of 2.5% in 2025 and 4.7% in 2026; broad unemployment is forecast at 3.4% at each year-end.
Future credit losses may differ from current estimates amid uncertainty over the war’s economic effects and borrowers’ repayment capacity.
Solvency is sensitive to market variables, interest rates, assumptions and regulatory changes; actual outcomes may materially differ from model estimates.
Latest events from Clal Insurance Enterprises
- Markets and P&C gains restored profitability, while health reserves and war uncertainty weighed.CLIS
Q1 2024 - H1 returned to profit on stronger underwriting and card results despite weak markets.CLIS
Q2 2024 - 9M comprehensive income reached NIS 596m, supported by stronger investment returns and underwriting.CLIS
Q3 2024 - 2024 comprehensive income rose to NIS 956m as insurance and MAX expanded earnings.CLIS
Q4 2024 - Q1 earnings rose on stronger underwriting and Max, amid market and war-related uncertainty.CLIS
Q1 2025 - H1 core income rose modestly as strong insurance results met Q2 softness and a VAT provision.CLIS
Q2 2025 - Core income rose 12%; 2025 dividend reached NIS 400M.CLIS
Q4 2025 - Core income rose 13% as insurance and savings growth lifted Q1 results.CLIS
Q1 2026 - H1 earnings and AUM grew, alongside NIS 200M buyback and dividend plans.CLIS
Q2 2026